Single Arm, Open-Label, Multicenter, Registry Study of Revcovi® (elapegademase-lvlr) Treatment in ADA-SCID Patients Requiring Enzyme Replacement Therapy
Clinical Trial Grant
Administered By
Pediatrics, Allergy and Immunology
Awarded By
Leadiant Biosciences, Inc.
Start Date
March 17, 2021
End Date
June 30, 2022
Administered By
Pediatrics, Allergy and Immunology
Awarded By
Leadiant Biosciences, Inc.
Start Date
March 17, 2021
End Date
June 30, 2022